The U.S. Centers for Medicare and Medicaid Services has named Novo Nordisk’s Wegovy, Ozempic and Rybelsus as part of the ...

Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, or semaglutide, has been approved for the treatment of patients ...

Novo Nordisk shares were 9.5% higher after the pharmaceutical giant said an experimental weight-loss shot showed patients ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...

With (almost) no fees and unlimited refunds for ATM charges, Novo business checking is a good option for small-business owners on the go. But Novo’s customer support is lacking, and you can’t ...

That brings the total to 25 drugs that will have lower price tags under a historic new program that allows the government to ...

The firm said in a note Wednesday that despite Novo Nordisk's challenges with supply issues for its obesity drug Wegovy, the company anticipates an improvement in prescription levels in the coming ...

Novo Nordisk, Other Firms Meet Danish PM to Discuss ... makes the main active ingredient in its popular obesity and diabetes injections Wegovy and Ozempic in Denmark, and exports it to the United ...

Among business leaders in the meeting were Lars Fruergaard Jorgensen, CEO of Novo Nordisk (NOVOb.CO), opens ... popular obesity and diabetes injections Wegovy and Ozempic in Denmark, and exports ...